Distinct roles for toll and autophagy pathways in double-stranded RNA toxicity in a drosophila model of expanded repeat neurodegenerative diseases

Human Molecular Genetics

Volumn 22, Issue 14, 2013, Pages 2811-2819

  Samaraweera, Saumya E ^a   O'Keefe, Louise V ^a   Price, Gareth R ^b,c   Venter, Deon J ^b,c   Richards, Robert I ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^c MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; TOLL LIKE RECEPTOR;

ARTICLE; AUTOPHAGY; BRAIN TOXICITY; DEGENERATIVE DISEASE; DROSOPHILA; FEMALE; GLIA CELL; HUNTINGTON CHOREA; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; DISEASE MODELS, ANIMAL; DROSOPHILA PROTEINS; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; NEURONS; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84880308992     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt130     Document Type: Article

References (64)

1. Richards, R.I. (2001) Dynamic mutations: a decade of unstable expanded repeats in human genetic disease. Hum. Mol. Genet., 10, 2187-2194.
2. La Spada, A.R. and Taylor, J.P. (2010) Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat. Rev. Genet., 11, 247-258.
3. Orr, H.T. and Zoghbi, H.Y. (2007) Trinucleotide repeat disorders. Annu. Rev. Neurosci., 30, 575-621.
4. Sato, N., Amino, T., Kobayashi, K., Asakawa, S., Ishiguro, T., Tsunemi, T., Takahashi, M., Matsuura, T., Flanigan, K.M., Iwasaki, S. et al. (2009) Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n. Am. J. Hum. Genet., 85, 544-557.
5. Kobayashi, H., Abe, K., Matsuura, T., Ikeda, Y., Hitomi, T., Akechi, Y., Habu, T., Liu, W., Okuda, H. and Koizumi, A. (2011) Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Am. J. Hum. Genet., 89, 121-130.
6. DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Finch, N.A., Flynn, H., Adamson, J. et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72, 245-256.
7. Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Laaksovirta, H., van Swieten, J.C., Myllykangas, L. et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72, 257-268.
8. Li, L.B., Yu, Z., Teng, X. and Bonini, N.M. (2008) RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature, 453, 1107-1111.
9. McLeod, C.J., O'Keefe, L.V. and Richards, R.I. (2005) The pathogenic agent in Drosophila models of 'polyglutamine' diseases. Hum. Mol. Genet., 14, 1041-1048.
10. van Eyk, C.L., O'Keefe, L.V., Lawlor, K.T., Samaraweera, S.E., McLeod, C.J., Price, G.R., Venter, D.J. and Richards, R.I. (2011) Perturbation of the Akt/Gsk3-beta signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs. Hum. Mol. Genet., 20, 2783-2794.
11. Lawlor, K.T., O'Keefe, L.V., Samaraweera, S.E., van Eyk, C.L., McLeod, C.J., Maloney, C.A., Dang, T.H., Suter, C.M. and Richards, R.I. (2011) Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases. Hum. Mol. Genet., 20, 3757-3768.
12. Yu, Z., Teng, X. and Bonini, N.M. (2011) Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy. PLoS Genet., 7, e1001340.
13. Lawlor, K.T., O'Keefe, L.V., Samaraweera, S.E., van Eyk, C.L. and Richards, R.I. (2012) Ubiquitous expression of CUG or CAG trinucleotide repeat RNA causes common morphological defects in a Drosophila model of RNA-mediated pathology. PLoS One, 7, e38516.
14. Mankodi, A., Urbinati, C.R., Yuan, Q.P., Moxley, R.T., Sansone, V., Krym, M., Henderson, D., Schalling, M., Swanson, M.S. and Thornton, C.A. (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet., 10, 2165-2170.
15. Zu, T., Gibbens, B., Doty, N.S., Gomes-Pereira, M., Huguet, A., Stone, M.D., Margolis, J., Peterson, M., Markowski, T.W., Ingram, M.A. et al. (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl Acad. Sci. USA, 108, 260-265.
16. van Eyk, C.L., McLeod, C.J., O'Keefe, L.V. and Richards, R.I. (2012) Comparative toxicity of polyglutamine, polyalanine and polyleucine tracts in Drosophila models of expanded repeat disease. Hum. Mol. Genet., 21, 536-547.
17. Cho, D.H., Thienes, C.P., Mahoney, S.E., Analau, E., Filippova, G.N. and Tapscott, S.J. (2005) Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell, 20, 483-489.
18. Moseley, M.L., Zu, T., Ikeda, Y., Gao, W., Mosemiller, A.K., Daughters, R.S., Chen, G., Weatherspoon, M.R., Clark, H.B., Ebner, T.J. et al. (2006) Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat. Genet., 38, 758-769.
19. Ladd, P.D., Smith, L.E., Rabaia, N.A., Moore, J.M., Georges, S.A., Hansen, R.S., Hagerman, R.J., Tassone, F., Tapscott, S.J. and Filippova, G.N. (2007) An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet., 16, 3174-3187.
20. Chung, D.W., Rudnicki, D.D., Yu, L. and Margolis, R.L. (2011) A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression. Hum. Mol. Genet., 20, 3467-3477.
21. Sopher, B.L., Ladd, P.D., Pineda, V.V., Libby, R.T., Sunkin, S.M., Hurley, J.B., Thienes, C.P., Gaasterland, T., Filippova, G.N. and La Spada, A.R. (2011) CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA. Neuron, 70, 1071-1084.
22. Banez-Coronel, M., Porta, S., Kagerbauer, B., Mateu-Huertas, E., Pantano, L., Ferrer, I., Guzman, M., Estivill, X. and Marti, E. (2012) A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet., 8, e1002481.
23. Bjorkqvist, M., Wild, E.J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R.V., Benn, C.L., Soulet, D. et al. (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J. Exp. Med., 205, 1869-1877.
24. Marek, D., Papin, S., Ellefsen, K., Niederhauser, J., Isidor, N., Ransijn, A., Poupon, L., Spertini, F., Pantaleo, G., Bergmann, S. et al. (2012) Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10. J. Neuroinflammation, 9, 238.
25. Luo, L., Liao, Y.J., Jan, L.Y. and Jan, Y.N. (1994) Distinct morphogenetic functions of similar small GTPases: Drosophila Drac1 is involved in axonal outgrowth and myoblast fusion. Genes & Development, 8, 1787-1802.
26. Jin, P., Zarnescu, D.C., Zhang, F., Pearson, C.E., Lucchesi, J.C., Moses, K. and Warren, S.T. (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron, 39, 739-747.
27. Mutsuddi, M., Marshall, C.M., Benzow, K.A., Koob, M.D. and Rebay, I. (2004) The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr. Biol., 14, 302-308.
28. Houseley, J.M., Wang, Z., Brock, G.J., Soloway, J., Artero, R., Perez-Alonso, M., O'Dell, K.M. and Monckton, D.G. (2005) Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila. Hum. Mol. Genet., 14, 873-883.
29. de Haro, M., Al-Ramahi, I., De Gouyon, B., Ukani, L., Rosa, A., Faustino, N.A., Ashizawa, T., Cooper, T.A. and Botas, J. (2006) MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. Hum. Mol. Genet., 15, 2138-2145.
30. Sofola, O.A., Jin, P., Botas, J. and Nelson, D.L. (2007) Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Hum. Mol. Genet., 16, 2326-2332.
31. Le Mee, G., Ezzeddine, N., Capri, M. and Ait-Ahmed, O. (2008) Repeat length and RNA expression level are not primary determinants in CUG expansion toxicity in Drosophila models. PLoS One, 3, e1466.
32. Freeman, M. (1996) Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell, 87, 651-660.
33. Ni, J.Q., Liu, L.P., Binari, R., Hardy, R., Shim, H.S., Cavallaro, A., Booker, M., Pfeiffer, B.D., Markstein, M., Wang, H. et al. (2009) A Drosophila resource of transgenic RNAi lines for neurogenetics. Genetics, 182, 1089-1100.
34. Ni, J.Q., Markstein, M., Binari, R., Pfeiffer, B., Liu, L.P., Villalta, C., Booker, M., Perkins, L. and Perrimon, N. (2008) Vector and parameters for targeted transgenic RNA interference in Drosophila melanogaster. Nat. Methods, 5, 49-51.
35. Kennerdell, J.R. and Carthew, R.W. (2000) Heritable gene silencing in Drosophila using double-stranded RNA. Nat. Biotechnol., 18, 896-898.
36. Hetru, C. and Hoffmann, J.A. (2009) NF-kappaB in the immune response of Drosophila. Cold Spring Harb. Perspect. Biol., 1, a000232.
37. De Gregorio, E., Spellman, P.T., Rubin, G.M. and Lemaitre, B. (2001) Genome-wide analysis of the Drosophila immune response by using oligonucleotide microarrays. Proc. Natl Acad. Sci. USA, 98, 12590-12595.
38. Irving, P., Troxler, L., Heuer, T.S., Belvin, M., Kopczynski, C., Reichhart, J.M., Hoffmann, J.A. and Hetru, C. (2001) A genome-wide analysis of immune responses in Drosophila. Proc. Natl Acad. Sci. USA, 98, 15119-15124.
39. Tanji, T., Hu, X., Weber, A.N. and Ip, Y.T. (2007) Toll and IMD pathways synergistically activate an innate immune response in Drosophila melanogaster. Mol. Cell. Biol., 27, 4578-4588.
40. Kauppila, S., Maaty, W.S., Chen, P., Tomar, R.S., Eby, M.T., Chapo, J., Chew, S., Rathore, N., Zachariah, S., Sinha, S.K. et al. (2003) Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene, 22, 4860-4867.
41. Shin, J.Y., Fang, Z.H., Yu, Z.X., Wang, C.E., Li, S.H. and Li, X.J. (2005) Expression of mutant Huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol., 171, 1001-1012.
42. Hayashi, Y., Kakita, A., Yamada, M., Koide, R., Igarashi, S., Takano, H., Ikeuchi, T., Wakabayashi, K., Egawa, S., Tsuji, S. et al. (1998) Hereditary dentatorubral-pallidoluysian atrophy: detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain. Acta Neuropathol., 96, 547-552.
43. Bradford, J., Shin, J.Y., Roberts, M., Wang, C.E., Sheng, G., Li, S. and Li, X.J. (2010) Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J. Biol. Chem., 285, 10653-10661.
44. Kretzschmar, D., Tschape, J., Bettencourt Da Cruz, A., Asan, E., Poeck, B., Strauss, R. and Pflugfelder, G.O. (2005) Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila. Glia, 49, 59-72.
45. Tamura, T., Sone, M., Yamashita, M., Wanker, E.E. and Okazawa, H. (2009) Glial cell lineage expression of mutant ataxin-1 and huntingtin induces developmental and late-onset neuronal pathologies in Drosophila models. PLoS One, 4, e4262.
46. Sepp, K.J., Schulte, J. and Auld, V.J. (2001) Peripheral glia direct axon guidance across the CNS/PNS transition zone. Dev. Biol., 238, 47-63.
47. Levine, B., Mizushima, N. and Virgin, H.W. (2011) Autophagy in immunity and inflammation. Nature, 469, 323-335.
48. Bowie, A.G. and Fitzgerald, C.A. (2007) RIG-I: tri-ing to discriminate between self and non-self RNA. TRENDS Immunol., 28, 147-150.
49. Fullaondo, A. and Lee, S.Y. (2012) Identification of putative miRNA involved in Drosophila melanogaster immune response. Dev. Comp. Immunol., 36, 267-273.
50. Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Easton, D.F., Duden, R., O'Kane, C.J. et al. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet., 36, 585-595.
51. Bilen, J. and Bonini, N.M. (2007) Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet., 3, 1950-1964.
52. Menzies, F.M., Huebener, J., Renna, M., Bonin, M., Riess, O. and Rubinsztein, D.C. (2010) Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain, 133, 93-104.
53. Xu, Y., Jagannath, C., Liu, X.D., Sharafkhaneh, A., Kolodziejska, K.E. and Eissa, N.T. (2007) Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity, 27, 135-144.
54. Delgado, M.A., Elmaoued, R.A., Davis, A.S., Kyei, G. and Deretic, V. (2008) Toll-like receptors control autophagy. EMBO J, 27, 1110-1121.
55. Nakamoto, M., Moy, R.H., Xu, J., Bambina, S., Yasunaga, A., Shelly, S.S., Gold, B. and Cherry, S. (2012) Virus recognition by Toll-7 activates antiviral autophagy in Drosophila. Immunity, 36, 658-667.
56. Into, T., Inomata, M., Takayama, E. and Takigawa, T. (2012) Autophagy in regulation of Toll-like receptor signaling. Cell Signal., 24, 1150-1162.
57. Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K. et al. (2012) Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature, 485, 251-255.
58. von Bernhardi, R., Tichauer, J.E. and Eugenin, J. (2010) Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J. Neurochem., 112, 1099-1114.
59. Khoshnan, A., Ko, J., Watkin, E.E., Paige, L.A., Reinhart, P.H. and Patterson, P.H. (2004) Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J. Neurosci., 24, 7999-8008.
60. Messmer, K. and Reynolds, G.P. (1998) Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease. Neurosci. Lett., 241, 53-56.
61. Sapp, E., Kegel, K.B., Aronin, N., Hashikawa, T., Uchiyama, Y., Tohyama, K., Bhide, P.G., Vonsattel, J.P. and DiFiglia, M. (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol., 60, 161-172.
62. Pavese, N., Gerhard, A., Tai, Y.F., Ho, A.K., Turkheimer, F., Barker, R.A., Brooks, D.J. and Piccini, P. (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology, 66, 1638-1643.
63. Tai, Y.F., Pavese, N., Gerhard, A., Tabrizi, S.J., Barker, R.A., Brooks, D.J. and Piccini, P. (2007) Microglial activation in presymptomatic Huntington's disease gene carriers. Brain, 130, 1759-1766.
64. Bischof, J., Maeda, R.K., Hediger, M., Karch, F. and Basler, K. (2007) An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc. Natl Acad. Sci. USA, 104, 3312-3317.